Morbidity and mortality after treatment of Ewing sarcoma: A single ‐institution experience

ConclusionPatients with ES are at high risk for relapse/progression and second cancers.

Source: Pediatric Blood and Cancer - April 18, 2017 Category: Cancer & Oncology Authors: Danielle Novetsky Friedman, Katherine Chastain, Joanne F. Chou, Chaya S. Moskowitz, Roberto Adsuar, Leonard H. Wexler, Alexander J. Chou, Amelia DeRosa, Joanne Candela, Heather Magnan, Shawn Pun, Tamara Kahan, Suzanne L. Wolden, Paul A. Meyers, Kevin C. O Tags: RESEARCH ARTICLE Source Type: research